Eli Lilly and Company has joined forces with the UK Government’s Department for Science, Innovation and Technology (DSIT) to ...

LUND, SE / ACCESS Newswire / August 12, 2025 / Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) will publish the company's interim report for the first six months of 2025 on Thursday, August 21 ...

Following a planned succession process, the Board of Directors of Gubra has appointed Markus Rohrwild as the new CEO of the company effective September 8, 2025. Henrik Blou will step down after almost ...

Cambridge Cognition Holdings plc (AIM:COG), the brain health software group specialising in digital health products that advance brain health research and treatment, is pleased to announce the ...

Programme will include competition for healthcare stakeholders to submit innovative models of obesity care which may receive pilot funding. BASINGSTOKE, 12 August 2025 – Eli Lilly and Company and the ...

The global gastrointestinal devices market is projected to grow at a CAGR of ~7% during the forecast period. This expansion ...

The clinical data management systems market is expected to grow at a robust CAGR of 12% from 2025 to 2030. This growth is ...

The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...

ENIGMA-TRS 1 is an international, one-year, double-blind, placebo-controlled Phase III study in at least 600 patients; 12-week study results expected in Q4 2026Evenamide, a first-in-class glutamate ...

As padel grows in popularity, the wellness event "Strong Body, Strong Game" explores how core-focused therapies and aesthetic ...

The AI-based clinical trials solution provider is expected to grow at a robust CAGR of approximately 20-25% over the forecast ...

Half Year Results/Half Year Results12-Aug-2025 / 06:55 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Media ...